5-139478481-T-C
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_198282.4(STING1):c.548A>G(p.Asn183Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000768 in 1,613,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N183H) has been classified as Uncertain significance.
Frequency
Consequence
NM_198282.4 missense
Scores
Clinical Significance
Conservation
Publications
- STING-associated vasculopathy with onset in infancyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- familial chilblain lupusInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STING1 | NM_198282.4 | c.548A>G | p.Asn183Ser | missense_variant | Exon 6 of 8 | ENST00000330794.9 | NP_938023.1 | |
| STING1 | NM_001301738.2 | c.548A>G | p.Asn183Ser | missense_variant | Exon 6 of 7 | NP_001288667.1 | ||
| STING1 | NM_001367258.1 | c.191A>G | p.Asn64Ser | missense_variant | Exon 5 of 7 | NP_001354187.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STING1 | ENST00000330794.9 | c.548A>G | p.Asn183Ser | missense_variant | Exon 6 of 8 | 1 | NM_198282.4 | ENSP00000331288.4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152130Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000135 AC: 34AN: 251378 AF XY: 0.000132 show subpopulations
GnomAD4 exome AF: 0.0000814 AC: 119AN: 1461852Hom.: 0 Cov.: 34 AF XY: 0.0000715 AC XY: 52AN XY: 727224 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152130Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74320 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.548A>G (p.N183S) alteration is located in exon 6 (coding exon 4) of the TMEM173 gene. This alteration results from a A to G substitution at nucleotide position 548, causing the asparagine (N) at amino acid position 183 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not provided Uncertain:1
STING-associated vasculopathy with onset in infancy Uncertain:1
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 183 of the TMEM173 protein (p.Asn183Ser). This variant is present in population databases (rs201277595, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with TMEM173-related conditions. ClinVar contains an entry for this variant (Variation ID: 475207). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt TMEM173 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at